Literature DB >> 19426172

Can serotonin transporter genotype predict craving in alcoholism?

Nassima Ait-Daoud1, John D Roache, Michael A Dawes, Lei Liu, Xin-Qun Wang, Martin A Javors, Chamindi Seneviratne, Bankole A Johnson.   

Abstract

BACKGROUND: We hypothesize that functional control of the serotonergic system is regulated in part by differential expression of the serotonin (5-HT) transporter (5-HTT). Alcohol-dependent individuals with the LL/LS genotype (L-carriers), compared with those with the SS genotype, have a lower 5-HT neurotransmission, which we hypothesize would be associated with higher craving for alcohol among L-carriers. We hypothesize further that acute peripheral depletion of tryptophan (5-HT's precursor), while further reducing 5-HT function, might decrease auto-inhibition of 5-HT neuronal firing, thereby increasing 5-HT neurotransmission transiently and lowering alcohol craving.
METHODS: We tested these hypotheses by examining whether in 34 Hispanic alcohol-dependent individuals subjective and physiological cue craving for alcohol differed by genotype, age of onset of problem drinking, and tryptophan availability.
RESULTS: On subjective "urge to drink" and "crave for a drink," we found a significant (p < 0.05) main effect of genotype and cue, as well as an interaction among genotype, age of onset of problem drinking, and tryptophan depletion. For the physiological measure of pulse, there was a main effect of genotype. L-carriers had higher craving than their SS counterparts, an effect that decreased under tryptophan depletion. While craving in L-carriers increased with an earlier age of onset of problem drinking, the opposite effect was seen in those with the SS genotype.
CONCLUSION: These results not only provide support for the hypothesis that alcoholics who are L-carriers have greater alcohol craving and possibly greater propensity for drinking but also propose that there is an important 5-HTT gene-by-environment interaction that alters cue craving response for alcohol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426172      PMCID: PMC2747793          DOI: 10.1111/j.1530-0277.2009.00962.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  43 in total

Review 1.  Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis.

Authors:  B A Johnson
Journal:  Alcohol Clin Exp Res       Date:  2000-10       Impact factor: 3.455

2.  A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

Authors:  A Heinz; D W Jones; C Mazzanti; D Goldman; P Ragan; D Hommer; M Linnoila; D R Weinberger
Journal:  Biol Psychiatry       Date:  2000-04-01       Impact factor: 13.382

Review 3.  The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.

Authors:  Simon N Young; Marco Leyton
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

4.  Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimer's disease.

Authors:  R J Porter; B S Lunn; L L Walker; J M Gray; C G Ballard; J T O'Brien
Journal:  Am J Psychiatry       Date:  2000-04       Impact factor: 18.112

5.  Effects of acute tryptophan depletion on mood in bulimia nervosa.

Authors:  W H Kaye; K A Gendall; M H Fernstrom; J D Fernstrom; C W McConaha; T E Weltzin
Journal:  Biol Psychiatry       Date:  2000-01-15       Impact factor: 13.382

6.  Association of a critical CSF tryptophan threshold level with depressive relapse.

Authors:  Ronald M Salomon; John S Kennedy; Benjamin W Johnson; Dennis E Schmidt; Joseph Kwentus; Harry E Gwirtsman; Michael H Ebert
Journal:  Neuropsychopharmacology       Date:  2003-03-19       Impact factor: 7.853

Review 7.  Neuropharmacology of paroxetine.

Authors:  Charles B Nemeroff; Michael J Owens
Journal:  Psychopharmacol Bull       Date:  2003

Review 8.  Tryptophan depletion, serotonin, and depression: where do we stand?

Authors:  Alexander Neumeister
Journal:  Psychopharmacol Bull       Date:  2003

9.  Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia.

Authors:  Ismene L Petrakis; Stephanie O'Malley; Bruce Rounsaville; James Poling; Colette McHugh-Strong; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2003-11-21       Impact factor: 4.530

10.  Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence.

Authors:  Amira Pierucci-Lagha; Richard Feinn; Vania Modesto-Lowe; Robert Swift; Maggie Nellissery; Jonathan Covault; Henry R Kranzler
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

View more
  12 in total

Review 1.  Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.

Authors:  Miles D Thompson; George A Kenna
Journal:  Alcohol Alcohol       Date:  2015-08-26       Impact factor: 2.826

2.  Relationship between the serotonin transporter polymorphism and obsessive-compulsive alcohol craving in alcohol-dependent adults: a pilot study.

Authors:  Rachel D Thompson; Jaimee L Heffner; Judith A Strong; Thomas J Blom; Robert M Anthenelli
Journal:  Alcohol       Date:  2010-07-03       Impact factor: 2.405

Review 3.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.

Authors:  Chong-Bin Zhu; Kathryn M Lindler; Anthony W Owens; Lynette C Daws; Randy D Blakely; William A Hewlett
Journal:  Neuropsychopharmacology       Date:  2010-09-08       Impact factor: 7.853

Review 5.  Medication treatment of different types of alcoholism.

Authors:  Bankole A Johnson
Journal:  Am J Psychiatry       Date:  2010-06       Impact factor: 18.112

6.  Pharmacogenetic approach at the serotonin transporter gene as a method of reducing the severity of alcohol drinking.

Authors:  Bankole A Johnson; Nassima Ait-Daoud; Chamindi Seneviratne; John D Roache; Martin A Javors; Xin-Qun Wang; Lei Liu; J Kim Penberthy; Carlo C DiClemente; Ming D Li
Journal:  Am J Psychiatry       Date:  2011-01-19       Impact factor: 18.112

7.  Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.

Authors:  Michael A Dawes; John D Roache; Martin A Javors; Susan E Bergeson; Dawn M Richard; Charles W Mathias; Nassima Ait-Daoud; Donald M Dougherty; Bankole A Johnson
Journal:  J Stud Alcohol Drugs       Date:  2009-11       Impact factor: 2.582

Review 8.  Role of 5-hydroxytryptamine 1B (5-HT1B) receptors in the regulation of ethanol intake in rodents.

Authors:  Youssef Sari
Journal:  J Psychopharmacol       Date:  2012-10-31       Impact factor: 4.153

9.  Preliminary Evidence for cue-induced Alcohol Craving Modulated by Serotonin Transporter Gene Polymorphism rs1042173.

Authors:  Nassima Ait-Daoud; Chamindi Seneviratne; Justin B Smith; John D Roache; Michael A Dawes; Lei Liu; Xin-Qun Wang; Bankole A Johnson
Journal:  Front Psychiatry       Date:  2012-02-16       Impact factor: 4.157

10.  Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.

Authors:  George A Kenna; Nick Roder-Hanna; Lorenzo Leggio; William H Zywiak; James Clifford; Steven Edwards; John A Kenna; Jessica Shoaff; Robert M Swift
Journal:  Pharmgenomics Pers Med       Date:  2012-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.